延吉招聘

MAJOR ACCOUNTABILITIES：
1.Scientific Knowledge and Exchange
Possesses in-depth knowledge of therapeutic area, including related disease states and co-morbid medical conditions；
Possesses in-depth knowledge of UCB products, competitive products, and other therapeutic options within relevant disease states;
Reviews and critiques scientific publications;
Collects, analyzes, and communicates fair-balanced information concerning therapeutic area, treatment options, emerging standards of care, and competitive intelligence;
Addresses medical information inquiries ;
Provides effective clinical presentations to internal and external audiences and tailors presentations to meet specific audience needs ;
Conducts local roundtables and education programs that aim to satisfy the specific needs of individual KOLs and Institutions;
Serves as a scientific resource at key medical and scientific conferences, advisory boards, clinical investigator meetings, internal meetings, and patient advocacy group meetings.
2.KOL Development
Identifies national, regional, and local Key Opinion Leaders (KOLs);
Establishes and develops synergistic relationships with KOLs to expand research, advisory, and educational partnership opportunities;
Assures thoughtful exchange of current medical information related to UCB products and therapeutic areas of clinical development with KOLs;
Provides educational and scientific support to KOLs as needed;
Identifies and facilitates local networking opportunities between KOLs and internal and external colleagues;
Explores novel educational opportunities with healthcare associations and ancillary healthcare professionals
3.Territory Management
Understands the impact of UCB strategies upon day to day activities;
Generates thoughtful and appropriate Medical Affairs plans to maximize collaborative opportunities and to provide superior service for every KOL and institution;
Communicates and coordinates scientific opportunities with other UCB field based and internal colleagues;
Evaluates each KOL individually to assure appropriate level of support.
4.Research
Assesses feasibility, facilitates submission, and serves as the primary liaison between UCB and investigator, for unsolicited Investigator-Initiated Studies (IISs) from inception to publication;
Assists in the identification of potential sites for UCB-sponsored clinical research programs and serves as a field-based scientist to support clinical trial programs as needed;
Serves as scientific resource at investigator meetings as needed.
5.Internal Functional Group/Commercialization Support
6.Team Development;
7.Administrative Duties;
8.Compliance and Pharmacovigilance
Complies at all times with UCB SOPs, compliance policies, and internal and external guidelines;
Serves as a resource to ensure that Adverse Events (AEs) are reported in accordance with our pharmacovigilance SOPs;
Ensures that questions related to AEs and safety are accurately addressed both internally and externally;

JOB PROFILE:
1.PharmD, PhD, or MD/DO required;
2.Minimum of 1 year MSL or industry–related experience strongly preferre;
3.Relevant therapeutic and clinical experience preferred;

比利时优时比制药公司（UCB）始建于1928年，总部设在比利时布鲁塞尔，在英国伦敦Slough和剑桥等地拥有2个研发中心。在八十年的发展中，优时比制药公司致力于为重症患者提供更多的创新治疗方法，造福人类。 优时比制药在全球业务遍布40多个国家，拥有近一万名员工。2010年全球销售收入32亿欧元。全球百强医药行业排名第33位。随着业务的不断拓展，2004年5月，优时比制药完成了对英国生物制药企业--细胞技术公司的收购。2007年9月1日，又完成了对德国许瓦兹制药集团的全球并购。至此，优时比制药公司成功地实现了全球领先的生物制药公司的战略定位。
优时比制药在华机构包括优时比贸易（上海）有限公司和珠海许瓦兹制药有限公司，业务遍及全国，产品涉及中枢神经系统疾病、变应性疾病、心血管疾病、贫血和疼痛治疗等领域。
创新、开拓、诚信、尽责、关爱、包容与业绩是优时比制药公司始终遵循的价值观。
面向未来，比利时优时比制药公司一如既往地秉承特有的业绩、尽责、诚信、包容、关爱、开拓和创新的价值观和企业文化，将建设一个全球生物医药的领先者，首要任务是带来专家和新药，治疗各种严重疾病的患者。
    
公司网站：******************
中文网站：************************

为什么选择我们？

卓越完善的人才发展战略
优时比业务的多样性和国际化为其员工提供了广阔的个人发展平台。员工一旦加入我们，就会得到公司在培训、业绩表现和个人潜力挖掘等方面提供的帮助。无论您的专业和职务是什么，您都将对自己的发展前景了然于胸。我们不仅提供正规的培训，而且还通过精良的个人发展计划和在职培训等途径为您的前途指路。

有竞争力的薪酬体系
从长远来看，为了吸引人才，保留人才，并激励人才，我们确保所提供的薪资福利具有市场竞争力。我们期待着员工能有优秀的表现并得到优厚的回报，因而把薪资和员工对公司的贡献直接联系起来。
上海总公司地址：上海市西藏中路268号来福士广场办公楼2802室

欢迎有意向的候选人可将简历投递至邮箱：chinacampus@ucb.com。应聘简历请在主题中注明申请职位名称。